Foreign Funds Help Spark China Stocks' Rebound

Gene Linn |

Foreign Funds Help Spark China Stocks' ReboundWhether you call it a correction or a consolidation, the pause in China Stocks’ October rally didn’t last long as the inflow of foreign funds sparked a solid rise Wednesday.

Hong Kong’s blue-chip Hang Seng Index rebounded from a three-day slide by rising 1.0% to 21,642. The index had climbed 10-straight trading days before last Friday. The index of Chinese companies, which began its consolidation earlier last week, increased 1.2% to 10,582.

Turnover was modest, but the Hong Kong Monetary Authority’s release of HK$2.7 billion into the market indicated foreign funds were coming in and putting upward pressure on the Hong Kong dollar.

The recent brief downturn was a consolidation, not a correction, according to Peter So, managing director and co-head of research at CCB International.

High-beta stocks like Chinese properties and the Hong Kong Exchanges and Clearing Ltd (0388, HK) would lead the recovery, he told Equities. “Infrastructure stocks will recover faster than the market because they have been under pressure recently,” he added.

So’s year-end target for the Hang Seng is 22,500. End


Hong Kong Blue Chips: +213, +1.0, to 21,642, 10-31-12, Hang Seng Index

Chinese Stocks in Hong Kong: +124, +1.2%, to 10,582, 10-31-12, HSCE Index

Shanghai Stocks: +6, +0.3% to 2,069, 10-31-12, Shanghai Composite Index.

Chinese Stocks in the U.S.: -4.4, 386.8, 10-26-12, Bank of New York Mellon, ADR Index-China - closed by storm

Insight: Hong Kong blue chips ended a three-day slump as the Hong Kong Monetary Authority injected HK$2.7 billion into the local market. The rise in funds helped Chinese banks and local properties. Chinese shipping companies rose on the back of good earnings reports: China Shipping (CSDXY) +7.1%. KGI Research

Quotable: "Market will show its true colour after the index futures expiry yesterday." BOCOM International. 10-31-12

Chinese Company to Watch: China Petroleum and Chemical Company (SNP) "Going forward, we believe continued earnings recovery given an economic rebound and potential implementation of the new fuel policy will lift returns from the petrochemical segment and secure a stable refining margin." UOB Kay Hian. 10-30-12

Brokerages and analysts cited here have disclaimers on their websites emphasizing their statements are for information only. They do not endorse my blog, and I don’t endorse them.

For a list of Chinese companies sold in the U.S. and information on each company go to

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Symbol Name Price Change % Volume
FGEN FibroGen Inc 17.30 0.50 2.98 204,583


Emerging Growth

Star Navigation Systems Group Ltd.

Star Navigation Systems Group Ltd is engaged in the development, marketing and promotion of in-flight safety monitoring systems.

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…


Trustify provides trust and safety in both the digital and physical worlds through our vast network of on-demand Private Investigators.By removing the large retainers and high hourly rates that traditional…